secwatch.observer — SEC 8-K summary
======================================

Issuer:     Astrana Health, Inc. (ASTH)
CIK:        0001083446
Form:       8-K
Filed at:   2022-11-03T23:59:59+00:00
Accession:  0001628280-22-028272
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ApolloMed Q3 revenue up 40% to $317M; net income down to $26M; raises full-year guidance
--------------------------------------------------------------------------------

- Q3 revenue $317M (+40% YoY); net income $26M vs $34.3M; diluted EPS $0.56 vs $0.74.
- Adjusted EBITDA $57.1M (revised calculation) vs $62.9M prior year; nine-month revenue $850M (+47%).
- Closed acquisition of All American Medical Group (Oct 31) adding >15,000 members; acquired Valley Oaks Medical Group (9 clinics) serving 20,000 patients.
- Raised FY2022 revenue guidance to $1.095-1.115B, net income to $50.5-67M, EBITDA to $107.5-133.5M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1083446/000162828022028272/0001628280-22-028272-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1083446/000162828022028272/ameh-20221103.htm
  HTML page:      https://secwatch.observer/filing/0001628280-22-028272

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer